|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| C07D 471/02 | (2006.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/4545 | (2006.01) |
| (11) | Number of the document | 3355884 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16852640.8 |
| Date of filing the European patent application | 2016-09-29 | |
| (97) | Date of publication of the European application | 2018-08-08 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-28 |
| (46) | Date of publication of the claims translation | 2021-07-26 |
| (86) | Number | PCT/US2016/054549 |
| Date | 2016-09-29 |
| (87) | Number | WO 2017/059139 |
| Date | 2017-04-06 |
| (30) | Number | Date | Country code |
| 201562235900 P | 2015-10-01 | US |
| (72) |
MYLES, David, C., US
KUSHNER, Peter, J., US
HARMON, Cyrus, L., US
|
| (73) |
Olema Pharmaceuticals, Inc. ,
512 2nd Street, 4th Floor, San Francisco, CA 94107,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Tetrahidro-1H-pirido[3,4-b]indolo antiestrogeniniai vaistai |
| TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLE ANTI-ESTROGENIC DRUGS |
| Payment date | Validity (years) | Amount | |
| 2025-09-18 | 10 | 231.00 EUR |
| 2026-09-29 |